TCIM
UTHR icon

TIAA CREF Investment Management’s United Therapeutics UTHR Stock Holding History

TIAA CREF Investment Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$7.65M Sell
65,141
-3,733
-5% -$435K 0.01% 1188
2018
Q4 		$7.5M Buy
68,874
+2,418
+4% +$280K 0.01% 1107
2018
Q3 		$8.5M Sell
66,456
-25,201
-27% -$3.12M 0.01% 1203
2018
Q2 		$10.4M Sell
91,657
-65,355
-42% -$7.18M 0.01% 1137
2018
Q1 		$17.6M Buy
157,012
+17,631
+13% +$2.24M 0.01% 818
2017
Q4 		$20.6M Sell
139,381
-1,377
-1% -$175K 0.01% 779
2017
Q3 		$16.5M Sell
140,758
-1,989
-1% -$254K 0.01% 855
2017
Q2 		$18.5M Sell
142,747
-85,161
-37% -$10.6M 0.01% 800
2017
Q1 		$30.9M Buy
227,908
+1,424
+0.6% +$216K 0.02% 590
2016
Q4 		$32.5M Buy
226,484
+23,049
+11% +$2.94M 0.02% 569
2016
Q3 		$24K Buy
203,435
+23,660
+13% +$2.84M 0.02% 704
2016
Q2 		$19M Buy
179,775
+1,465
+0.8% +$163K 0.01% 747
2016
Q1 		$19.9M Sell
178,310
-203,839
-53% -$25.8M 0.02% 746
2015
Q4 		$59.8M Sell
382,149
-25,165
-6% -$3.66M 0.04% 399
2015
Q3 		$53.5M Sell
407,314
-33,432
-8% -$5.36M 0.04% 431
2015
Q2 		$76.7M Buy
440,746
+219,465
+99% +$39.5M 0.05% 360
2015
Q1 		$38.2M Buy
221,281
+106,798
+93% +$16.3M 0.03% 563
2014
Q4 		$14.8M Buy
114,483
+12,341
+12% +$1.59M 0.01% 884
2014
Q3 		$13.1M Sell
102,142
-22,349
-18% -$2.3M 0.01% 931
2014
Q2 		$11M Sell
124,491
-1,492
-1% -$143K 0.01% 1090
2014
Q1 		$11.8M Sell
125,983
-232,084
-65% -$23.7M 0.01% 1034
2013
Q4 		$40.5M Sell
358,067
-28,065
-7% -$2.53M 0.03% 549
2013
Q3 		$30.4M Sell
386,132
-17,970
-4% -$1.31M 0.02% 611
2013
Q2 		$26.6M Buy
+404,102
New +$26M 0.02% 620

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TIAA CREF Investment Management's UTHR Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its United Therapeutics (UTHR) stake by 5.4% in Q1 2019, selling an estimated $435K and leaving 65,141 shares worth $7.65M. The position accounts for 0.01% of the portfolio, ranked #1188.

TIAA CREF Investment Management first reported a position in UTHR in Q2 2013 and has held it in 24 quarters since. The position peaked at $76.7M in Q2 2015. 378 funds tracked by Wall St. Rank hold UTHR as of Q1 2019.

  • TIAA CREF Investment Management held 65,141 shares of United Therapeutics worth $7.65M as of Q1 2019.
  • TIAA CREF Investment Management sold 3,733 United Therapeutics shares in Q1 2019, an estimated $435K.
  • United Therapeutics made up 0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1188 holding.
  • TIAA CREF Investment Management first reported a position in United Therapeutics in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's United Therapeutics position peaked at $76.7M in Q2 2015.
  • 378 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.